However, the Met, Lut-L, and Lut-H treatment groups counteracted the trends associated with diabetic-induced weight loss and hyperglycemia, although these differences did not reach statistical significance ( Figure 4B and C ).
← all excerpts
Luteolin Alleviates Diabetic Nephropathy Fibrosis Involving AMPK/NLRP3/TGF-β Pathway.
1
—
—